Company intelligence / Profile preview

Walgreens Health Initiatives

Deerfield, Illinois, USA

Ownership: Private
Development stage: Other

Overview

Walgreens Health Initiatives (WHI) was the pharmacy benefit management (PBM) subsidiary of Walgreens. The company provided a comprehensive suite of services including mail-service pharmacy, specialty pharmacy, and health and wellness programs designed for employers, health plans, and third-party administrators. WHI focused on optimizing prescription drug spend and improving clinical outcomes through data-driven health management programs. In 2011, Walgreens sold WHI to Catalyst Health Solutions for $525 million as part of a strategic shift to focus on its core retail pharmacy and specialty pharmacy businesses. Following subsequent industry consolidations, the business eventually became part of OptumRx under UnitedHealth Group.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Walgreens Health Initiatives.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Walgreens Health Initiatives.

Explore the full profile